Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its ...

Europe has been falling behind on clinical trials over the past decade as pharmaceutical companies shift their focus to the ...

As the disease progresses to moderate dementia, damage in areas of the brain that control language, reasoning, conscious thought, and sensory processing lead to more severe symptoms.

Two novel peptides derived from Protagonist's proprietary discovery platform are in advanced Phase 3 clinical development ... the timing of JNJ-2113 and rusfertide clinical trials, and timing of ...

At this markup phase, a chart will show a consistent upward trend ... We also reference original research from other reputable publishers where appropriate. You can learn more about the standards ...

Genelux has dosed the first subject in the Phase II VIRO-25 clinical trial in the US, designed to assess the systemic ...

Shuttle Pharmaceuticals Holdings announced it has finalized agreements with all six of the planned site enrollment locations to administer the Phase 2 clinical trial of Ropidoxuri ...

After the recent FDA approval for the promising schizophrenia drug Cobenfy (xanomeline and trospium chloride), Bristol Myers ...

Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule ...

According to a new market research report, 'IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering ...